Abstract:ASD (Autism Spectrum Disorders) are NDDs (Neurodevelopmental Disorders) with complex etiology including multiple genetic and environmental factors.Non-coding mutations contribute to the multifactorial etiology of ASD by influencing gene activity through various regulatory mechanisms. Advances in genomic technologies, such as whole-genome sequencing (WGS) and chromatin interaction studies, have highlighted the role of non-coding regions in ASD genetics.Identifying these non-coding variants enhances our understanding of the underlying complex genetic landscape ASD. This study aims to analyze the impact of non-coding mutations within regulatory regions in Autism Spectrum Disorder (ASD). The research builds upon a cohort of 360 Spanish ASD trios, from which 200 trios were selected after excluding cases with known copy number variants (CNVs) and whole-exome sequencing (WES) mutations. The selection process intentionally enhanced the sample for undiscovered non-coding risk variants by excluding cases with de novo loss-of-function mutations or large de novo CNVs. To identify regulatory regions of interest, the study employed targeting sequencing of a selection of candidate cis-regulatory elements (cCREs) from ENCODE v2. De novo variation and rare inherited variation were studied using different bioinformatic pipelines and their impact on regulatory activities was assessed using a deep-learning approach (Sei framework). Additional analysis including candidate gene elucidation using ATAC-seq and PLAC-seq data in neuronal cells, variant prioritization, protein-protein interaction (PPI) network,Transcription Factor (TF) enrichment, presence in topologically associated domains (TADs) were also carried out. Sex bias in regulatory variation within ASD was also explored in our analysis.We discovered that 28% of de novo variants and 25% of inherited variants with high regulatory potential were found in patients with negative results from whole-exome sequencing (WES) and microarray analyses, as assessed by Sei. By integrating PLAC-Seq data, we functionally annotated approximately 80% of de novo variants and 85% of inherited variants. While resources like ENCODE provide valuable insights into genomic regulatory elements, it is crucial to be cautious when prioritizing specific regulatory elements based on initial hypotheses regarding their impact on gene regulation: many sequence classes associated with ASD in this study did not show significant enrichment in any particular cCRE signature. Notably, the most important observation in this study is the implication of a global dysregulation of CTCF suggesting a potential mechanistic impact on the chromatin architecture. In addition,We have found that the most high-impact regulatory variants-whether de novo or inherited-are linked to genes not previously associated with ASD. Nevertheless, gene ontology (GO) enrichments indicate that both coding and non-coding variations likely interact within already characterized ASD pathways.

Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing

Diagnosis of Prader-Willi syndrome and Angelman syndrome by targeted nanopore long-read sequencing

A multi-model approach defines function altering MECP2 missense variants identified in individuals with autism spectrum disorder

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

Locus-specific DNA methylation of Mecp2 promoter leads to autism-like phenotypes in mice

Hypermethylation of the enolase gene ( ENO2 ) in autism

Genome-wide DNA methylation profiles of autism spectrum disorder

Identification of Autism-Related MECP2 Mutations by Whole-Exome Sequencing and Functional Validation

Sex-specific DNA methylation signatures of autism spectrum disorder in newborn blood

Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation

Deciphering the Non-Coding Genome in Autism Spectrum Disorders (ASD): A Study of De Novo and Rare Inherited Variants through Targeted Sequencing in Regulatory Regions

Concordance of whole-genome long-read sequencing with standard clinical testing for Prader-Willi and Angelman syndromes

Fine Mapping Regulatory Variants by Characterizing Native CpG Methylation with Nanopore Long Read Sequencing

Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development

Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics

Short report on a distinct electroencephalogram endophenotype for MTHFR gene variation co-occurring in autism spectrum disorder

Genetic Insights from a Molecular Pathway Analysis on Two Independent Samples of Autistic Patients

Targeted Sequencing and Clinical Strategies in Children with Autism Spectrum Disorder: A Cohort Study

Evaluating the regulatory function of non‐coding autism‐associated single nucleotide polymorphisms on gene expression in human brain tissue

Enrichment of a subset of Neanderthal polymorphisms in autistic probands and siblings

Truncated variants of MAGEL2 are involved in the etiologies of the Schaaf-Yang and Prader-Willi syndromes